These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31585888)

  • 1. Anti-inflammatory therapy in atherosclerosis.
    Kocyigit D; Gurses KM; Tokgozoglu L
    Front Biosci (Landmark Ed); 2020 Jan; 25(2):242-269. PubMed ID: 31585888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime?
    Hansen PR
    Curr Pharm Des; 2018; 24(3):281-290. PubMed ID: 29318966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of atherosclerosis.
    Arsenault BJ; Kritikou EA; Tardif JC
    Curr Cardiol Rep; 2012 Aug; 14(4):443-9. PubMed ID: 22706914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
    Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
    Front Immunol; 2019; 10():1378. PubMed ID: 31275317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and Targeting Coronary Artery Inflammation.
    West HW; Antoniades C
    Antioxid Redox Signal; 2021 May; 34(15):1217-1243. PubMed ID: 32458744
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular disease management through restrained inflammatory responses.
    Jabir NR; Tabrez S
    Curr Pharm Des; 2016; 22(7):940-6. PubMed ID: 26648461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canakinumab for secondary prevention of coronary artery disease.
    Ortega-Paz L; Capodanno D; Angiolillo DJ
    Future Cardiol; 2021 May; 17(3):427-442. PubMed ID: 33533289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory Therapeutics and Coronary Artery Disease.
    Eghtedari B; Roy SK; Budoff MJ
    Cardiol Rev; 2023 Mar-Apr 01; 31(2):80-86. PubMed ID: 35471811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
    Muhammad K; Ayoub MA; Iratni R
    Curr Pharm Des; 2021; 27(18):2141-2150. PubMed ID: 33461451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Sensitivity C-reactive Protein (hsCRP) and its Implications in Cardiovascular Outcomes.
    Denegri A; Boriani G
    Curr Pharm Des; 2021; 27(2):263-275. PubMed ID: 32679014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.
    Golia E; Limongelli G; Natale F; Fimiani F; Maddaloni V; Pariggiano I; Bianchi R; Crisci M; D'Acierno L; Giordano R; Di Palma G; Conte M; Golino P; Russo MG; Calabrò R; Calabrò P
    Curr Atheroscler Rep; 2014 Sep; 16(9):435. PubMed ID: 25037581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases.
    Fu H; Ni M; Chen JK; Zhao T; Deng YP; Li DJ; Jiang GJ; Shen FM
    Curr Drug Targets; 2017; 18(15):1779-1784. PubMed ID: 26302792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
    Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
    Bouabdallaoui N; Tardif JC
    Curr Cardiol Rep; 2021 Jul; 23(9):120. PubMed ID: 34269908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.